Back to Massachusetts

H3269 • 2025

An Act establishing a transferable pediatric cancer research tax credit

An Act establishing a transferable pediatric cancer research tax credit

Taxes
Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Marcus S. Vaughn
Last action
2026-04-21
Official status
Accompanied a study order, see H5313
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act establishing a transferable pediatric cancer research tax credit

An Act establishing a transferable pediatric cancer research tax credit By Representative Vaughn of Wrentham, a petition (accompanied by bill, House, No.

What This Bill Does

  • An Act establishing a transferable pediatric cancer research tax credit By Representative Vaughn of Wrentham, a petition (accompanied by bill, House, No.
  • 3269) of Marcus S.
  • Vaughn for legislation to establish a transferable pediatric cancer research tax credit.
  • Revenue.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-04-21 House

    Accompanied a study order, see H5313

  2. 2026-02-25 House

    Reporting date extended to Wednesday, March 18, 2026

  3. 2025-12-18 House

    Reporting date extended to Friday, February 20, 2026

  4. 2025-09-16 Joint

    Hearing rescheduled to 09/16/2025 from 10:30 AM-12:30 PM in A-1 and Virtual Hearing updated to New End Time

  5. 2025-09-05 Joint

    Hearing scheduled for 09/16/2025 from 10:30 AM-01:00 PM in A-1

  6. 2025-02-27 House

    Referred to the committee on Revenue

  7. 2025-02-27 Senate

    Senate concurred

Official Summary Text

An Act establishing a transferable pediatric cancer research tax credit
By Representative Vaughn of Wrentham, a petition (accompanied by bill, House, No. 3269) of Marcus S. Vaughn for legislation to establish a transferable pediatric cancer research tax credit. Revenue.

Current Bill Text

Read the full stored bill text
×

Bill H.3269

SECTION 1. Chapter 63 of the General Laws is hereby amended by inserting after section 38J the following section:-

Section 38J ½. (a) In addition to any other credit allowed pursuant to this chapter, a pediatric cancer research institution shall be allowed a transferable tax credit for expenditures related to pediatric cancer research. For the purposes of this section, a "pediatric cancer research institution" shall mean a hospital located within the commonwealth that is equipped for, and actively conducting, pediatric cancer research.

(b) The total aggregate amount of tax credits allowed pursuant to this section shall not exceed $10,000,000 in a fiscal year.

(c) A pediatric cancer research institution eligible for the this credit may transfer the credits, in whole or in part, to any individual or entity, and the transferee shall be entitled to apply the credits against the tax with the same effect as if the transferee had incurred the expenditures related to pediatric cancer research itself.

(d) Any pediatric cancer research institution that receives a credit pursuant to this section for any taxable year may carry over and apply to its tax due for any 1 or more of the next succeeding 3 taxable years the portion, as reduced from year to year, of the credit that exceeds any tax due for the taxable year.

(e) The commissioner of revenue may promulgate regulations necessary to carry out this section.

SECTION 2. Section 38J½ of chapter 63 of the General Laws is hereby repealed.

SECTION 3. Section 1 shall be effective for the taxable year beginning on or after January 1, 2025.

SECTION 4. Section 2 shall take effect on January 1, 2033.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close